Not applicableStudy completedNCT03488199
What this trial is testing
The SIBERIA Trial (Acculink™ Versus CGuard™)
Who this might be right for
Patients With Aterosclerotic Carotid StenosisSymptomatic Patients (Stenosis > 50%)Asymptomatic Patients (Stenosis ≥80%)
Meshalkin Research Institute of Pathology of Circulation 100